Ford offers US$78 million for Romanian auto plant

Saturday, September 8, 2007

Ford Motor Company, the U.S. car maker, will reportedly pay €57 million (US$78 million) for a 72.4 percent stake in the Romanian assembly plant Automobile Craiova, a Romanian official said Friday.

“The offer of Ford Motor Company for a 72.4 percent stake is €4.1556 per share or €57 million overall,” said Sebastian Vladescu, head of the State Property Agency (AVAS), after opening Ford’s improved offer. Vladescu added that the contract may be signed on September 12, during the auto show in Frankfurt.

The Romanian government bought back the Craiova-based car maker from Daewoo Motors, in late 2006 for US$51 million. As the Korean company was bankrupt, the government had to pay another $10 million for debts stemming from past loans. Ford is the only bidder for the purchase of the factory.

According to Washington Post, many auto-part makers have set up in the new European Union member country, attracted by cheap labor, favourable tax rates and the rising output of Renault’s Dacia plant. The vice president of Dacia, Constantin Stroe, said that the price Ford offers is not important. “It’s important to have the factory working as soon as possible”, he added. “With this production facility, Romania will become an important auto production center in Europe”, concluded Stroe, cited by HotNews.

RELATED POST

The Comprehensive Guide To Real Estate Investing

The Comprehensive Guide to Real Estate Investing Real estate investing can be a lucrative way to build wealth over time.…

The 10 Best Online Courses On Digital Marketing

The 10 Best Online Courses on Digital Marketing Introduction to Digital Marketing Courses In today's digital age, enhancing your marketing…

Understanding The Cost Of Dental Implants

Understanding the Cost of Dental Implants When considering dental implants, it's essential to understand the various factors affecting the price.…

What To Do After A Root Canal

What To Do After a Root Canal Undergoing a root canal can be a daunting experience for many patients, but…